Revenue
2020
2021
2022
2023
2024
2025
CVRx, Inc. (CVRX)
Price—Loading quote
Net income
2020
2021
2022
2023
2024
2025
Free cash flow
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | $56.7M | $51.3M | $39.3M | $22.5M | $13.0M | $6.1M |
| Gross profit | $48.3M | $43.0M | $33.0M | $17.5M | $9.4M | $4.6M |
| Research & development | $11.1M | $11.1M | $11.6M | $10.0M | $7.5M | $6.4M |
| Operating expenses | $99.6M | $102.4M | $76.1M | $60.0M | $35.4M | $16.1M |
| Operating income | −$51.3M | −$59.5M | −$43.1M | −$42.5M | −$26.0M | −$11.5M |
| Net income | −$53.3M | −$60.0M | −$41.2M | −$41.4M | −$43.1M | −$14.1M |
| Basic EPSper diluted share | -$2.04 | -$2.65 | -$1.99 | -$2.02 | -$4.16 | -$37.01 |
| Diluted EPSper diluted share | -$2.04 | -$2.65 | -$1.99 | -$2.02 | -$4.16 | -$37.01 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 2, 2026Form 4 · 10b5-1 | Adamson Philip B.Chief Medical Officer | SellCommon Stock | 1.3K | $7.90 | $10.0K | 61.6K |
| Mar 2, 2026Form 4 · 10b5-1 | John Robert AllenChief Revenue Officer | SellCommon Stock | 4.0K | $7.90 | $31.3K | 86.0K |
| Mar 2, 2026Form 4 · 10b5-1 | VERRASTRO PAULCHIEF MKTG & STRAT OFFICER | SellCommon Stock | 1.3K | $7.90 | $10.1K | 60.6K |
| Mar 2, 2026Form 4 · 10b5-1 | OASHEIM JAREDCHIEF FINANCIAL OFFICER | SellCommon Stock | 1.7K | $7.90 | $13.8K | 96.7K |
| Mar 2, 2026Form 4 · 10b5-1 | Hykes KevinPRES & CEO | SellCommon Stock | 7.8K | $7.90 | $61.3K | 284.2K |